Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine hCG before fresh embryo transfer in ART
IRCT20230803059016N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of human chorionic gonadotropin and progesterone in infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Embryo implantation rate, Clinical pregnancy rate and 2 more. Started Aug 2023; status: completed.
02
Drugs
human chorionic gonadotropinprogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20230803059016N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230803059016N1.